Clinical Trial Update: Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating recombinant human interferon beta-1a (Avonex) for HTLV-1-associated myelopathy has completed; the snippet does not include trial outcom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1 Infection
• Htlv-1-associated Myelopathy
• Tropical Spastic Paraparesis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: HTLV-I Infection, Spinal Cord Disease | Phase 2 | Status: COMPLETED